Saturday, June 20, 2026
In Detail Full day, Saturday, June 20, 2026, Timezone: America/Chicago
Hathal Haddad: 28 Days Until Brachytherapy Awareness Day 2026
oncodaily - Hathal Haddad, Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared a post on LinkedIn: “28 Days Until Brachytherapy Awareness Day 2026 The Original Adaptive […]
AI Summary: Radiation oncologists and advocates are publicly gearing up for Brachytherapy Awareness Day, using countdowns and outreach to raise awareness of image‑guided and salvage brachytherapy techniques. The push emphasizes education, patient access and the specialty’s role in targeted cancer treatment — all packaged with the predictable mix of pride and promotional zeal.
- Countdown and technique spotlights ahead of Brachytherapy Awareness Day (4)
- Guidelines, re-irradiation debates and professional meeting updates (4)
Countdown and technique spotlights ahead of Brachytherapy Awareness Day
Guidelines, re-irradiation debates and professional meeting updates
More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
Natalie Krebs, Iowa Public Radio / kffhealthnews - Amid advancements in treatment and screening, more Americans are surviving the disease. But many are left with psychological scars, such as lingering anxiety and depression.
AI Summary: New analyses show cancer survival rates have improved, yet many survivors continue to face persistent mental‑health burdens including anxiety, depression and social isolation. Experts call for integrated psychosocial care, routine screening and long‑term support services to address survivorship needs, arguing that beating cancer shouldn’t mean signing up for a second, emotional marathon.
- MASCC 2026: Global spotlight on supportive cancer care (4)
- Practical survivorship needs: rehab, fertility, cardiac care (5)
- Psychosocial oncology programs, research and education initiatives (4)
- Rising survivorship, rising mental‑health burdens (5)
- All Other Stories
MASCC 2026: Global spotlight on supportive cancer care
Practical survivorship needs: rehab, fertility, cardiac care
Psychosocial oncology programs, research and education initiatives
Rising survivorship, rising mental‑health burdens
All Other Stories
Purdue Researchers Develop Next-Generation Automated Platform to Accelerate Drug Discovery – Purdue Institute for Cancer Research
oncodaily - Purdue Institute for Cancer Research shared a post on LinkedIn: “Purdue researchers, including Nicolás Morato and R. Graham Cooks, have developed a next-generation platform that integrates chemical synthesis, biological testing, […]
AI Summary: Purdue researchers unveiled an automated mass‑spectrometry platform that compresses key steps of small‑molecule drug discovery into a matter of hours, promising faster lead identification and screening. The system couples high‑throughput chemistry with rapid readouts to accelerate iteration cycles, potentially shrinking timelines and costs for early oncology drug development — welcome news for impatient scientists.
Dementia care: Re‑envisioning the role of music
medicalxpress - As a certified music therapist, I have observed firsthand the many ways music can bring meaning and beauty into people's lives, even under very difficult circumstances. Much of my clinical work and research has occurred in dementia care. Here, music is of…
AI Summary: Clinicians and care teams are repositioning music from a pleasant diversion to a core therapeutic tool in dementia care. Targeted music interventions are shown to soothe agitation, trigger memories, support communication and daily routines, and empower caregivers. Programs emphasize personalized playlists, staff training and integrating music into clinical care pathways—because sometimes a song works where a pill does not.
- Care priorities, prevention and sensory supports for dementia (4)
- Music and expressive non-drug therapies in dementia care (4)
Care priorities, prevention and sensory supports for dementia
Music and expressive non-drug therapies in dementia care
One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
fiercehealthcare - Amazon One Medical reported a security event impacting a "limited number" of patients of its senior care clinics business.
AI Summary: One Medical (Amazon One Medical) disclosed a cybersecurity/data‑breach incident tied to a third‑party vendor that affected a limited number of patients in its seniors’ care unit. The organization is investigating, notifying impacted individuals and reviewing vendor safeguards — a routine reminder that healthcare convenience and outsourced tech sometimes collide unpleasantly.
Teclistamab Significantly Improves Survival Among Patients with Multiple Myeloma Who Previously Received One To Three Lines of Treatment
esmo - Findings from the MajesTEC-9 study
AI Summary: Clinical data show teclistamab significantly improves survival for patients with multiple myeloma after one to three prior therapies. Those results have ignited discussions about moving the bispecific antibody earlier in treatment algorithms and prompted labs and clinicians to reassess sequencing strategies across relapsed and refractory myeloma.
Novel electronic health record-based marker can identify at-risk transplant patients and reduce organ rejection
medicalxpress - A new multicenter study led by researchers at the Icahn School of Medicine at Mount Sinai suggests that a novel electronic health record-based marker can help clinicians identify transplant patients at high risk for organ rejection because they are not ta…
AI Summary: Teams developed and validated an electronic‑health‑record derived marker that flags transplant recipients at elevated risk of organ rejection. The tool integrates routinely collected clinical data to trigger earlier review and intervention, promising to reduce rejection events if deployed thoughtfully within clinical workflows rather than buried in another alert pile.
Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae
Melis N. Anahtar, Jacqueline A. Valeri, Seyed Majed Modaresi, Aarti Krishnan, Nina M. Donghia, Saman / science - Science Translational Medicine, Volume 18, Issue 854, June 2026.
AI Summary: Researchers used deep‑learning screening of millions of compounds to identify two promising leads active against drug‑resistant Neisseria gonorrhoeae. The AI‑driven approach accelerated hit discovery and produced chemical scaffolds now entering preclinical follow‑up, offering a potential new avenue in an area desperate for novel antibiotics.
IRhythm discloses data stolen from third-party applications in cyberattack
Ricky Zipp / healthcaredive - The cardiac monitoring company said that a threat actor has demanded payment in exchange for not publicly releasing the stolen data.
AI Summary: IRhythm announced a cybersecurity incident involving stolen data from third‑party applications and is investigating the breach. Limited patient information may have been exposed, prompting notifications and security reviews. The episode starkly illustrates how digital‑health vendors remain attractive targets and how compromises of ancillary systems can ripple into real patient risk.
FDA approves Welireg with pembrolizumab for renal cell carcinoma
medicalxpress - The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma in adults with a clear ce…
AI Summary: The FDA cleared Welireg (belzutifan) in combination with pembrolizumab for adjuvant treatment of renal cell carcinoma at high risk of recurrence after surgery. The approval expands belzutifan’s indications, offering a new post‑nephrectomy option intended to lower recurrence risk and reflecting regulators’ willingness to endorse targeted therapy combinations in kidney cancer.
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Healthcare Finance, None, Drug Development, Hearing Loss and look for the RSS link.
StackHealth Time Machine
More StackHealth